We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The...
CLEVELAND, March 18, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2023 and provided an update on progress toward...
CLEVELAND, March 05, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The...
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -1.56046814044 | 7.69 | 8.45 | 7.2 | 295548 | 7.76970215 | CS |
4 | 0.09 | 1.20320855615 | 7.48 | 8.45 | 7.06 | 217401 | 7.62112083 | CS |
12 | 2.82 | 59.3684210526 | 4.75 | 9.01 | 4.0245 | 367673 | 6.94682587 | CS |
26 | 3.3 | 77.2833723653 | 4.27 | 9.01 | 3.7 | 266717 | 6.1977865 | CS |
52 | 4.6 | 154.882154882 | 2.97 | 9.01 | 2.83 | 209494 | 5.3581774 | CS |
156 | 6.11 | 418.493150685 | 1.46 | 9.01 | 0.1303 | 895601 | 1.27631061 | CS |
260 | -0.45 | -5.61097256858 | 8.02 | 9.01 | 0.1303 | 1206020 | 1.95223798 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions